» Articles » PMID: 30223827

Ameliorative Effect of Taurine-chloramine in Azathioprine-induced Testicular Damage; a Deeper Insight into the Mechanism of Protection

Overview
Publisher Biomed Central
Date 2018 Sep 19
PMID 30223827
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The male reproductive system is a sensitive and intricate process that can be distressed following exposure to various toxicants. Therapeutic drugs, especially chemotherapeutics, can also adversely affect male fertility by instigating hormonal changes leading to testicular cells injury. Azathioprine (AZA) is an effective anticancer drug, but some cases of testicular toxicity have been reported. The aim of this work was to investigate the protective effects of taurine chloramine (TAU-Cl), a reported antioxidant and antiinflammtory peptide, against AZA-induced testicular dysfunction in male rats and ascertain the contributing mechanisms.

Methods: Forty male rats were allocated into four equal groups; (i) normal control rats, (ii) TAU-Cl group (100 mg/kg b.w/day for 10 weeks, (iii) AZA group (5 mg/day for 4 weeks); (iv) TAU-Cl/AZA group.

Results: AZA caused increased DNA damage in the testes, and alterations in sex hormones and sperm quality, including sperm count, viability, and motility. Moreover, testicular tissue from the AZA-treated group had increased levels of oxidative stress indicator, MDA, and decreased activity of the antioxidant enzymes as superoxide dismutase (SOD), reduced glutathione (GSH) and catalase (CAT) levels. These deleterious events were accompanied by upregulated levels of the pro-inflammatory cytokines, tumor necrosis factor-alpha (TNF-α), and protein expression of iNOS and NFκB-p65, interleukin-1beta (IL-1β), and proapoptotic marker; caspase-9, together with decreased Bcl-2, NrF2 and hemeoxygenase (HO-1) expression. In contrast, TAU-Cl pretreatment significantly abrogated these toxic effects which were confirmed histologically.

Conclusion: Pretreatment with TAU-Cl exerts a protective effect against AZA-induced male reproductive testicular atrophy. This finding could open new avenues for the use of TAU-Cl as a complementary approach to chemotherapy supportive care.

Citing Articles

A narrative review and new insights into the protective effects of taurine against drug side effects.

Keshavarzi M, Naraki K, Razavi B, Hosseinzadeh H Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(1):203-230.

PMID: 39141023 DOI: 10.1007/s00210-024-03331-0.


Zishen Yutai Pill improves sperm quality and reduces testicular inflammation in experimental varicocele rats.

Peng M, Wang W, Zhu W, Bai Y, Ning N, Huang Q Heliyon. 2023; 9(6):e17161.

PMID: 37484236 PMC: 10361325. DOI: 10.1016/j.heliyon.2023.e17161.


-Floral Honey and Multi-Floral Honey versus Oil against Testicular Degeneration Rat Model: The Possible Protective Mechanisms.

Almujaydil M, Algheshairy R, Alhomaid R, Alharbi H, Ali H Nutrients. 2023; 15(7).

PMID: 37049533 PMC: 10096533. DOI: 10.3390/nu15071693.


Efficacy of Inhaled N-Chlorotaurine in a Mouse Model of and Pneumonia.

Speth C, Rambach G, Windisch A, Neurauter M, Maier H, Nagl M J Fungi (Basel). 2022; 8(5).

PMID: 35628790 PMC: 9143854. DOI: 10.3390/jof8050535.


Studying the mechanism of sperm DNA damage caused by folate deficiency.

Wang W, Peng M, Yuan H, Liu C, Zhang Y, Fang Y J Cell Mol Med. 2021; 26(3):776-788.

PMID: 34953021 PMC: 8817123. DOI: 10.1111/jcmm.17119.


References
1.
Duan P, Hu C, Butler H, Quan C, Chen W, Huang W . 4-Nonylphenol induces disruption of spermatogenesis associated with oxidative stress-related apoptosis by targeting p53-Bcl-2/Bax-Fas/FasL signaling. Environ Toxicol. 2016; 32(3):739-753. DOI: 10.1002/tox.22274. View

2.
Zhang Z, Liu D, Yi B, Liao Z, Tang L, Yin D . Taurine supplementation reduces oxidative stress and protects the liver in an iron-overload murine model. Mol Med Rep. 2014; 10(5):2255-62. PMC: 4199407. DOI: 10.3892/mmr.2014.2544. View

3.
Gottardi W, Nagl M . Chemical properties of N-chlorotaurine sodium, a key compound in the human defence system. Arch Pharm (Weinheim). 2002; 335(9):411-21. DOI: 10.1002/1521-4184(200212)335:9<411::AID-ARDP411>3.0.CO;2-D. View

4.
Harleman J, Nolte T . Testicular toxicity: regulatory guidelines--the end of formaldehyde fixation?. Toxicol Pathol. 1997; 25(4):414-7; discussion 418. DOI: 10.1177/019262339702500415. View

5.
Polifka J, Friedman J . Teratogen update: azathioprine and 6-mercaptopurine. Teratology. 2002; 65(5):240-61. DOI: 10.1002/tera.10043. View